PAGE UNDER CONSTRUCTION
Cholesterols and lipids are one of the essential substances the body uses to transport energy and vitamins and mentain cell’s mebranes health .
The values we measure in blood are the sum:
- nutritional origin
- endogenous production – metabolism
They are used as independent markers of cardiovascular risk and vascular stenosis. and the appearance of obstructive heart disease (myocardial infarction), brain (brain), lung (pulmonary embolism).
In assessing potential dyslipidemia and calculating cardiovascular risk, multiple parameters are required. The basic parameters or the set of examinations that follow may be used in the lipid profile, as appropriate :
It is the total of the diet obtained (exclusively from animal dietary derivatives) and the endogenous produced by the liver. In a proportionally healthy diet, dietary participation is usually 20-25% of the total statistical source of cheese, and generally dairy, and then fatty meats
High Density Cholesterol (HDL)
It is the protective – “good” cholesterol that we want as high as possible. Its adjustment is through good nutrition, exercise (walking), and smoking cessation.
Low Density Cholesterol (LDL)
It is the harmful – “bad” cholesterol which we regulate mainly nutritionally (avoiding animal fats) and then pharmaceutical if necessary.
These are the lipids that are highly dependent on the diet and fat we consume. In addition to their importance for cardiovascular, their potentially high values are evaluated as an indicator of metabolic disturbance and risk in pancreatic function.
It is the total of lipids that are associated with atherosclerotic disease – cardiovascular risk and metabolic disorder.
It is the ratio of cholesterol to HDL and shows the extent to which HDL effectively protects the vessels from total cholesterol.
Liporotein-a [Lp (a)]
Independent lipid, which is an additional risk factor for atherosclerosis and cardiovascular disease. It is used as an additional element in assessing the potential pathogenesis of cholesterol and triglycerides
Very High Density Cholesterol (VLDL)
Fraction of cholesterol, which is independently evaluated as a cardiovascular – metabolic risk indicator.
Apolipoprotein A1 (Apo-A1)
It gives additional insight into the protective capability of HDL.
Apolipoprotein B (Apo-B and Apo-B100)
It gives additional insight into the severity of LDL.
Apolipoprotein E (Apo-E)
It is evaluated for the assessment of specific types of dyslipidaemia and the efficacy of statin medication.
OPTIONAL SCREENING TESTS IN CASES OF DYSLIPIDAIMIA
- High Sensitivity CRP / Fibrinogen / Homocysteine Indications of Intravascular Inflammation
- Genetic control of thrombophilia
OPTIONAL CONTROL IN STATION DRAINAGE
- ALT / AST transaminases control liver hepatitis
- CPK control Muscle drug control – rhabdomyolysis
IMAGING SCREENING FOR ATHEROMATOSIS ASSESSMENT
The following tests are performed to assess atherosclerosis under the criteria of age personal and family history
- Ultrasound Triplex Heart
- Ultrasound Triplex Carotid
Information selected with sources:
- Interpretation of Diagnostic Tests – J.Wallach
The selection of the examinations is done with absolutely individual criteria. The exact choice is the responsibility of your treating physician
Editor: John Gratis Lab Director / Clinical Biochemist
Medical Tests performed with analytical systems and reagents
by SIEMENS-USA & BECMAN COULTER-USA
Recommendations -preparation for blood sampling :
- A meal the previous night is mandatory.
- The last meal should be taken up to 11-12 hours before blood sampling.
- The evening meal is preferred to include the least possible animal fats.
- No meal should be taken in the morning. Coffee without sugar and water are free.
- Results are given within 2-3 hours.
The Basic Screening Check Up is in Special Offer at 31 Euros